Factors associated with preventability, predictability, and severity of adverse drug reactions

Annals of Pharmacotherapy

Volumn 33, Issue 2, 1999, Pages 236-240

  Gholami, Kheirollah ^a   Shalviri, Gloria ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Adverse drug reactions; Iran

Indexed keywords

DRUG;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CHILD; DRUG SURVEILLANCE PROGRAM; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; PREDICTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHILD; DRUG MONITORING; FEMALE; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; IRAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE;

EID: 0033014010     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.17440     Document Type: Article

References (17)

1. Requirements for adverse reactions reporting. Geneva: World Health Organization, 1975.
2. Manasse H Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm 1989:46:929-44.
3. Brennan T, Leape L, Iaird N, Herbert L, Localio R, Lawthers A, et al. Incidence of adverse drug events and negligence in hospitalized patients: results of Harvard Medical Practice Study I. N Engl J Med 1991;324: 370-6.
4. DeSwarte R. Drug allergy: problems and strategies. J Allergy Clin Immunol 1984;74:209-24.
5. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Hosp Pharm 1989;46:336-7.
6. Davies DM. Textbook of adverse drug reactions. 2nd ed. New York: Oxford University Press, 1981.
7. Middleton K. Adverse drug reactions and drug induced disease. Clinical Pharmacy and Therapeutics. 5th ed. Baltimore, MD: Williams and Wilkins, 1992:20-36.
8. Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
9. Schumock GT, Thomton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992:27:538.
10. Hartwig S, Siegel J, Schneider P. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:2229-32.
11. Breathnach S, Hintner H. eds. Classification and mechanisms of drug reactions. In: Adverse drug reactions and the skin. Oxford: Blackwell Scientific, 1992:14-38.
12. Burnun J. Preventability of adverse drug reactions (letter). Ann Intern Med 1976;85:80.
13. Bosh TK, Schurtz, Swerlein A, et al. Identification of preventable adverse drug reactions using medical record E-Codes. Paper presented at 49th American Society of Hospital Pharmacy Annual Meeting. Washington, DC, June 2, 1992.
14. Porter J, Jick H. Drug related deaths among medical inpatients. JAMA 1977;237:879-81.
15. Melmon K. Preventable drug reactions - causes and cures. N Engl J Med 1971;284:1361-8.
16. Clyne KE, German MR. Adverse drug reaction reporting: focus on cost and prevention. P&T 1992;17:1145-56.
17. Pearson T, Pittman D, Longly J, Grapes Z, Viglotti J, Mullis S. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994;51:2268-72.